XML 72 R61.htm IDEA: XBRL DOCUMENT
v3.25.2

Deferred Royalty Obligations, Net - Additional Information (Details) - USD ($) $ in Thousands |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | --- | ---
Jun. 27, 2025 | Jan. 17, 2024 | Jun. 30, 2025 | Dec. 31, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Amortization of debt discount and issuance costs |  |  |  |  | $ 1,436 | $ 937 | $ 2,548 | $ 1,868
Funding Agreement |  |  |  |  |  |  |  |
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Funding payment received, net of certain transaction expenses |  | $ 500,000 |  | $ 500,000 |  |  |  |
Percentage of royalty interest payments on net sales |  | 5.00% |  |  |  |  |  |
Royalty interest payments equal to cap amount |  | $ 950,000 |  |  |  |  |  |
Royalty interest payments may adjust to maximum rate |  | 10.00% |  |  |  |  |  |
Interest expense |  |  |  |  | 25,800 |  | 49,800 |
Amortization of debt discount and issuance costs |  |  |  |  | 3,300 |  | 6,300 |
Net cash proceeds |  |  |  | 472,500 |  |  |  |
Royalty obligation debt discount and issuance costs paid in cash |  |  |  | 27,500 |  |  |  |
Fair value of embedded derivatives liability |  |  | $ 35,600 | 41,100 | $ 35,600 |  | $ 35,600 |
Effective interest rate |  |  | 20.40% |  | 20.40% |  | 20.40% |
Funding Agreement | Other Current Liabilities |  |  |  |  |  |  |  |
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Royalty interest payable |  |  | $ 3,900 | $ 100 | $ 3,900 |  | $ 3,900 |
Royalty Interest Purchase and Sale Agreement | Eidos Therapeutics, Inc |  |  |  |  |  |  |  |
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Cash purchased price | $ 300,000 |  |  |  |  |  |  |
Percentage of royalty payment equal to annual cap | 60.00% |  |  |  |  |  |  |
Annual net sales | $ 500,000 |  |  |  |  |  |  |
Percentage of purchase price equal to hard cap | 145.00% |  |  |  |  |  |  |
Proceeds from royalty obligation under interest purchase and sale agreement |  |  | 297,000 |  |  |  |  |
Royalty obligation debt issuance costs |  |  | $ 3,000 |  |  |  |  |
Royalty Purchase Agreement |  |  |  |  |  |  |  |
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Interest expense |  |  |  |  | $ 300 |  | $ 300 |
Effective interest rate |  |  | 10.80% |  | 10.80% |  | 10.80% |
Royalty Purchase Agreement | Other Current Liabilities |  |  |  |  |  |  |  |
Deferred Royalty Obligations [Line Items] |  |  |  |  |  |  |  |
Royalty interest payable |  |  | $ 900 |  | $ 900 |  | $ 900 |

X
- Definition Annual net sales. + References No definition available. + Details
Name: | bbio_AnnualNetSales
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash Purchased Price. + References No definition available. + Details
Name: | bbio_CashPurchasedPrice
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Deferred Royalty Obligations. + References No definition available. + Details
Name: | bbio_DeferredRoyaltyObligationsLineItems
Namespace Prefix: | bbio_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Funding payment received net of certain transaction expenses. + References No definition available. + Details
Name: | bbio_FundingPaymentReceivedNetOfCertainTransactionExpenses
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of purchase price equal to hard cap. + References No definition available. + Details
Name: | bbio_PercentageOfPurchasePriceEqualToHardCap
Namespace Prefix: | bbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty interest payments on net sales. + References No definition available. + Details
Name: | bbio_PercentageOfRoyaltyInterestPaymentsOnNetSales
Namespace Prefix: | bbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty payment equal to annual cap. + References No definition available. + Details
Name: | bbio_PercentageOfRoyaltyPaymentEqualToAnnualCap
Namespace Prefix: | bbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from royalty obligation under funding agreement. + References No definition available. + Details
Name: | bbio_ProceedsFromRoyaltyObligationUnderFundingAgreement
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proceeds from royalty obligation under interest purchase and sale agreement. + References No definition available. + Details
Name: | bbio_ProceedsFromRoyaltyObligationUnderInterestPurchaseAndSaleAgreement
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty interest payable. + References No definition available. + Details
Name: | bbio_RoyaltyInterestPayable
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Royalty interest payments equal to cap amount. + References No definition available. + Details
Name: | bbio_RoyaltyInterestPaymentsEqualToCapAmount
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty interest payments may adjust to maximum rate. + References No definition available. + Details
Name: | bbio_RoyaltyInterestPaymentsMayAdjustToMaximumRate
Namespace Prefix: | bbio_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty obligation debt discount and issuance costs. + References No definition available. + Details
Name: | bbio_RoyaltyObligationDebtDiscountAndIssuanceCosts
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalty obligation debt issuance costs. + References No definition available. + Details
Name: | bbio_RoyaltyObligationDebtIssuanceCosts
Namespace Prefix: | bbio_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69E -Publisher FASB -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69F -Publisher FASB -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3 + Details
Name: | us-gaap_AmortizationOfFinancingCostsAndDiscounts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)(a)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6 + Details
Name: | us-gaap_DebtInstrumentInterestRateEffectivePercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 49 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=bbio_FundingAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=bbio_RoyaltyInterestPurchaseAndSaleAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=bbio_EidosTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=bbio_RoyaltyPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |